Delivery Order SPE2DB20D1100-SPE2DB25FA2L0
Award Date
1/24/25
Potential Completion Date
1/27/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,364.74 firm fixed-price delivery order contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product. The contract has an ultimate completion date of January 14, 2025 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,525.37, is for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of May 9, 2023. The contract is not designated with a set-aside, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $9,201.62 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a broad range...
This federal contract award is for the delivery of medical supplies, specifically Adbry 150 mg/ml syringes, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,573.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of December 22, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,377.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through February 6, 2025. The contract does not have a set-aside designation, indicating it was competitively awarded. In addition to this Delivery Order,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $18,567.28 firm-fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has a period of performance through September 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military healthcare system. This award is likely part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 firm fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $25,144.72 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ADBRY 150 MG/ML SYRINGE/ML, a pharmaceutical product. This delivery order contract has a completion date of February 6, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a...
This federal contract award, valued at $21,986.28, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $33,144.37, is a Firm Fixed Price Delivery Order for the provision of pharmaceutical products and medical supplies. The contract has a final completion date of September 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...